Sign in to post a message. UTHR, looks to be overvalued at this price https://hotstocks123.blogspot.com just allerted a new stock - it beats having to dig online yourself for new stock ideas. UTHR has just seen the last of the selling. Looks …
On the charts, the stock has advanced a solid 8.4% year-to-date to trade at ... Following yesterday's positive news from the Food and Drug Administration (FDA) and subsequent 2.1% pop, UTHR received some positive analyst attention. …
Based on fundamentals, market trends, company events and news, and other factors, equity analysts assign price targets and recommendations to buy or sell a stock. The following graph shows how a survey of multiple analysts recommend …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR Keywords: United Therapeutics, …
UTHR commands market capitalization of $3.38 billion, and it reported its latest EPS at $5.63. Its stock grew more than 63.57 percent in the past 52 weeks. The stock is mildly volatile with its beta at 0.93.Register withStockCall and …
From 2007 through 2012, Dr. Sullivan was the Chief Medical Officer of United Therapeutics Corporation (“United Therapeutics”; Nasdaq: UTHR). From 2006 to 2012, Dr. Sullivan also served as the Chief Medical Officer of Lung Rx, …
Given up for dead just weeks ago the biotech sector is suddenly back with a vengeance. Seemingly everyone’s favorite …
Assuming they didn’t get out of this mess whole already, wealthy Russians might want to take what’s left of their deposits after a potential 40% heist in Cyprus and invest it in their home country. That’s if today’s “call of the day” is on ...
(AP) _ United Therapeutics Corp. (UTHR) on Wednesday reported fourth-quarter earnings of $110.3 million. The Silver Spring, Maryland-based company said it had net income of $2.43 per share. Earnings, adjusted for stock option …
United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. The Company markets and …